Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Guadecitabine in Treating Patients with Wild-Type Gastrointestinal Stromal Tumor, Pheochromocytoma, Paraganglioma, or Kidney Cancer

Trial Status: administratively complete

This phase II trial studies how well guadecitabine works in treating patients with wild-type gastrointestinal stromal tumor, pheochromocytoma, paraganglioma, or kidney cancer. Guadecitabine may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.